Patents by Inventor Talbot Presley

Talbot Presley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160100595
    Abstract: The rate of degradation of a cooked food product that is maintained at an elevated temperature can be reduced by the use of an encapsulated environment food holder. The encapsulated environment is a small, airtight or semi-airtight containment vessel that retains compositions that escape from a cooked food product over time. The volume of an encapsulated environment is greater than one hundred percent but less than one-thousand percent of the cooked food product volume. By holding single servings or portions of a cooked food product in a small, encapsulated environment palatability or taste of a cooked food product can be extended.
    Type: Application
    Filed: December 18, 2015
    Publication date: April 14, 2016
    Inventors: Loren Veltrop, Phillip Grisham, Brook Grisham, Michael Rainone, Clint Thompson, Talbot Presley
  • Publication number: 20140197177
    Abstract: An encapsulated environment is an air-circulation-restricted volume, preferably just large enough to hold a single serving of a cooked, protein containing food product. Restricting the air circulation reduces the evaporation of gases and liquids that are normally lost over time. The palatability of a cooked, protein-containing food product is thus maintained by holding the cooked product at a ready-to-eat temperature inside of an encapsulated environment. The encapsulated environment is a compartment configured to hold a single serving of a cooked, protein-containing food product, the compartment being able to be covered or at least partially closed by its use in combination with a sleeve configured to receive a tray into which the compartment is formed.
    Type: Application
    Filed: January 14, 2014
    Publication date: July 17, 2014
    Applicant: Prince Castle, LLC.
    Inventors: Loren Veltrop, Mary Morgan, Phillip Grisham, Brook Grisham, Michael Rainone, Clint Thompson, Talbot Presley
  • Patent number: 8662187
    Abstract: A linear motor activator for a downhole safety valve including a permanent magnet carrier; a plurality of permanent magnets mounted to the permanent magnet carrier; a coil carrier disposed in magnetic field proximity to the permanent magnet carrier; and a plurality of coils mounted to the coil carrier, one of the permanent magnet carrier and the coil carrier being movable relative to the other of the permanent magnet carrier and coil carrier, and being connected to a component of a downhole safety valve and method.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: March 4, 2014
    Assignee: Baker Hughes Incorporated
    Inventors: Gary Lake, Michael J. May, Priyesh Ranjan, Douglas Murray, Michael Rainone, Samuel Sackett, Talbot Presley
  • Patent number: 8619257
    Abstract: Disclosed herein are methods and devices for detection of bacterial HAI. Disclosed methods may be utilized for continuous in vivo monitoring of a potential bacterial infection site and may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of infection. Disclosed methods include utilization of recombinant bacteriophage to deliver to pathogenic bacteria a translatable genetic sequence encoding an optically detectable marker or an enzyme capable of producing an optically detectable marker. Upon detection of the optical signal produced by the marker, medical personnel may be alerted to the presence of pathogenic bacteria at the site of inquiry. Any bacterial causative agent of HAI may be detected according to disclosed methods.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: December 31, 2013
    Assignee: Kimberley-Clark Worldwide, Inc.
    Inventors: Thomas Edward Plowman, Erica M. Phillips, Richard Hantke, Daniel Baird, Mike Rainone, Talbot Presley
  • Publication number: 20130156921
    Abstract: The rate of degradation of a cooked food product that is maintained at an elevated temperature can be reduced by the use of an encapsulated environment food holder. The encapsulated environment is a small, airtight or semi-airtight containment vessel that retains compositions that escape from a cooked food product over time. The volume of an encapsulated environment is greater than one hundred percent but less than one-thousand percent of the cooked food product volume. By holding single servings or portions of a cooked food product in a small, encapsulated environment palatability or taste of a cooked food product can be extended.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 20, 2013
    Applicant: PRINCE CASTLE, LLC
    Inventors: Loren Veltrop, Phillip Grisham, Brook Grisham, Michael Rainone, Clint Thompson, Talbot Presley
  • Publication number: 20130156911
    Abstract: The rate of degradation of a cooked food product that is maintained at an elevated temperature can be reduced by the use of an encapsulated environment food holder. The encapsulated environment is a small, airtight or semi-airtight containment vessel that retains compositions that escape from a cooked food product over time. By holding single servings or portions of a cooked food product in a small, encapsulated environment palatability or taste of a cooked food product can be extended.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 20, 2013
    Applicant: PRINCE CASTLE, LLC
    Inventors: Loren Veltrop, Phillip Grisham, Brook Grisham, MICHAEL RAINONE, CLINT THOMPSON, TALBOT PRESLEY
  • Patent number: 8280471
    Abstract: Disclosed are methods and devices for continuous in vivo monitoring of a potential bacterial infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of a hospital acquired infection, thereby providing for earlier intervention. Disclosed methods utilize optical fibers to deliver an excitation signal to an area in which pathogenic bacteria may exist. In the presence of the excitation signal, bacterial pathogens may autofluoresce with a unique spectral signature. Upon generation of a fluorescent emission, an optically detectable emission signal may be transmitted to a detection/analysis device. Analysis of the characteristics of the emission signal produced in response to the excitation signal may be used to determine the presence or concentration of pathogens at the site of inquiry, following which real time information may be transmitted to medical personnel via a wireless transmission system.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: October 2, 2012
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Mike Rainone, Erica M. Phillips, Richard Hantke, Shawn R. Feaster, Daniel Baird, Thomas Edward Plowman, Talbot Presley
  • Publication number: 20120143024
    Abstract: Disclosed herein are methods and devices for detection of bacterial HAI. Disclosed methods may be utilized for continuous in vivo monitoring of a potential bacterial infection site and may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of infection. Disclosed methods include utilization of recombinant bacteriophage to deliver to pathogenic bacteria a translatable genetic sequence encoding an optically detectable marker or an enzyme capable of producing an optically detectable marker. Upon detection of the optical signal produced by the marker, medical personnel may be alerted to the presence of pathogenic bacteria at the site of inquiry. Any bacterial causative agent of HAI may be detected according to disclosed methods.
    Type: Application
    Filed: December 13, 2007
    Publication date: June 7, 2012
    Applicant: Kimberly-Clark Worldwide, Inc.
    Inventors: Erica M. Phillips, Richard Hantke, Daniel Baird, Mike Rainone, Thomas Edward Plowman, Talbot Presley
  • Publication number: 20120143027
    Abstract: Disclosed herein are methods and devices for detection of hospital acquired infections. Disclosed methods may be utilized for continuous in vivo monitoring of a potential infection site and may be utilized to alert patients and/or health care providers to changes in the local environment due to the presence of a pathogen at an early stage of infection. Disclosed methods utilize ion sensitive field effect transistors (ISFETs) to detect changes in ionic concentration at the site due to the presence of a pathogen, for instance at a surgical site. When a pathogen is present, the local ionic concentration, and hence the electrical characteristics of an ISFET may change, causing a detectable signal from the ISFET. An ISFET may be associated with a biological material such as an enzyme or a specific binding partner for an expression product of a pathogen to improve detection.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 7, 2012
    Applicant: KIMBERLY-CLARK WORLDWIDE, INC.
    Inventors: Erica M. Phillips, Richard Hantke, Daniel Baird, Mike Rainone, Thomas Edward Plowman, Talbot Presley
  • Patent number: 8180421
    Abstract: Disclosed herein are methods and devices for detection of hospital acquired infections. Disclosed methods may be utilized for continuous in vivo monitoring of a potential infection site or for periodic in vitro monitoring of tissue or fluid from a patient and may be utilized to alert patients and/or health care providers to the presence of a pathogen at an early stage of infection. Disclosed methods utilize fluorophore pairs that optically interact with one another according to Forster resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) mechanism. One member of the pair or a cofactor that interacts with an enzyme to form a member of the pair may be tethered to a device by a substrate that is specific for an enzyme expressed by a targeted pathogen. Upon interaction of the enzyme with the substrate, an optically detectable signal may be altered or initiated, detection of which may then provide information as to the existence of the pathogen at the site.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: May 15, 2012
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Erica M. Phillips, Richard Hantke, Daniel Baird, Mike Rainone, Thomas Edward Plowman, Talbot Presley
  • Publication number: 20110037004
    Abstract: A linear motor activator for a downhole safety valve including a permanent magnet carrier; a plurality of permanent magnets mounted to the permanent magnet carrier; a coil carrier disposed in magnetic field proximity to the permanent magnet carrier; and a plurality of coils mounted to the coil carrier, one of the permanent magnet carrier and the coil carrier being movable relative to the other of the permanent magnet carrier and coil carrier, and being connected to a component of a downhole safety valve and method.
    Type: Application
    Filed: August 13, 2009
    Publication date: February 17, 2011
    Applicant: BAKER HUGHES INCORPORATED
    Inventors: Gary Lake, Michael J. May, Priyesh Ranjan, Douglas Murray, Michael Rainone, Samuel Sackett, Talbot Presley
  • Publication number: 20090156943
    Abstract: Disclosed are methods and devices for continuous in vivo monitoring of a potential bacterial infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of pathogenic bacteria at an early stage of a hospital acquired infection, thereby providing for earlier intervention and improved recovery rates from bacterial infection. Disclosed methods utilize optical fibers to deliver an excitation signal to an area in which pathogenic bacteria may exist. In the presence of the excitation signal, bacterial pathogens may autofluoresce with a unique spectral signature. Upon generation of a fluorescent emission, an optically detectable emission signal may be transmitted to a detection/analysis device.
    Type: Application
    Filed: December 12, 2007
    Publication date: June 18, 2009
    Applicant: Kimberly-Clark World Inc.
    Inventors: Erica M. Phillips, Daniel Baird, Richard Hantke, Shawn R. Feaster, Mike Rainone, Thomas Edward Plowman, Talbot Presley
  • Publication number: 20090155770
    Abstract: Disclosed are methods and devices for continuous in vivo monitoring of a potential infection site. Disclosed devices may be utilized to alert patients and/or health care providers to the presence of a pathogen at an early stage of a hospital acquired infection, thereby providing for earlier intervention and improved recovery rates from bacterial infection. Disclosed methods utilize implantable devices for location at an in vivo site. The implantable device is held in conjunction with an optical fiber that detects and transmits an optically detectable signal generated in the presence of a pathogen. Upon generation of the emission, the optically detectable emission signal may be transmitted to a portable detection/analysis device. Analysis of the characteristics of the emission signal produced may be used to determine the presence or concentration of pathogens at the site of inquiry, following which real time information may be transmitted to medical personnel, for instance via a wireless transmission system.
    Type: Application
    Filed: December 12, 2007
    Publication date: June 18, 2009
    Applicant: Kimberly-Clark Worldwide, Inc.
    Inventors: Tameka Brown, Akosua Atta-Mensah, Daniel Baird, Richard Hantke, Tod Hoover Shultz, Erica M. Phillips, Shawn R. Feaster, Mike Rainone, Thomas Edward Plowman, Talbot Presley
  • Publication number: 20090156942
    Abstract: Disclosed herein are methods and devices for detection of hospital acquired infections. Disclosed methods may be utilized for continuous in vivo monitoring of a potential infection site or for periodic in vitro monitoring of tissue or fluid from a patient and may be utilized to alert patients and/or health care providers to the presence of a pathogen at an early stage of infection. Disclosed methods utilize fluorophore pairs that optically interact with one another according to Forster resonance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) mechanism. One member of the pair or a cofactor that interacts with an enzyme to form a member of the pair may be tethered to a device by a substrate that is specific for an enzyme expressed by a targeted pathogen. Upon interaction of the enzyme with the substrate, an optically detectable signal may be altered or initiated, detection of which may then provide information as to the existence of the pathogen at the site.
    Type: Application
    Filed: December 12, 2007
    Publication date: June 18, 2009
    Applicant: Kimberly-Clark Worldwide, Inc.
    Inventors: Erica M. Phillips, Richard Hantke, Daniel Baird, Mike Rainone, Thomas Edward Plowman, Talbot Presley